TH123100A - Quinoxalene - and Clinoline - Carboxamike - Google Patents
Quinoxalene - and Clinoline - CarboxamikeInfo
- Publication number
- TH123100A TH123100A TH901002236A TH0901002236A TH123100A TH 123100 A TH123100 A TH 123100A TH 901002236 A TH901002236 A TH 901002236A TH 0901002236 A TH0901002236 A TH 0901002236A TH 123100 A TH123100 A TH 123100A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- substance
- alkyl
- replaced
- quinoxalene
- Prior art date
Links
- 239000000126 substance Substances 0.000 claims abstract 6
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 150000001204 N-oxides Chemical class 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 150000002148 esters Chemical class 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000012453 solvate Substances 0.000 claims abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 3
- -1 amino, amino Chemical group 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Abstract
DC60 (17/08/52) การประดิษฐ์เกี่ยวข้องกับสารประกอบของสูตร (I) (สูตรเคมี) (I) โดยที่หมู่แทนที่เป็นดังที่ถูกนิยามไว้ในรายละเอียดการประดิษฐ์, ในรูปอิสระ หรือ ในรูปของเกลือที่ สามารถยอมรับได้ทางเภสัชกรรม, โซลเวต, เอสเทอร์, N-ออกไซด์ของสารนั้น; กระบวนการสำหรับ การเตรียมของสารนั้น; กับ สารเภสัชกรรมที่ประกอบด้วยสารประกอบดังกล่าว โดยเฉพาะสำหรับการ ใช้ในหนึ่งหรือมากกว่าหนึ่งโรคที่สื่อโดยโปรตีน ไทโรซีน ไคเนส สิทธิบัตรยา DC60 (17/08/52) Invention involves a compound of formula (I) (chemical formula) (I) where the substitution group is, as is defined in the fabrication description, in its free form or in the form of salt. Pharmaceuticals, solvates, esters, N-oxides of the substance; Process for Preparation of the substance; With pharmaceutical substances containing such compounds Specifically for Use in one or more diseases mediated by the patent tyrosine kinase protein.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH123100A true TH123100A (en) | 2013-04-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201001682A1 (en) | Derivatives of phenyl and benzodioxynyl-substituted indazols | |
| EA201190235A1 (en) | SUBSTITUTED 1-CYANOETHYLGETHERO CYCLILCARBOXAMIDE COMPOUNDS 750 | |
| EA201200938A1 (en) | IMIDAZOPIRIDINE DERIVATIVES AS JAK INHIBITORS | |
| EA200701176A1 (en) | NEW NAPHTHALINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| NO20083909L (en) | Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor enhancers | |
| HRP20070076A2 (en) | Pyrimidine derivatives | |
| EA201201677A1 (en) | DERIVATIVES OF HETEROARILIMIDAZOLONE AS JAK INHIBITORS | |
| TW200833326A (en) | Chemical compounds 572 | |
| UY32025A (en) | SUBSTITUTED DERIVATIVES OF 6-CHLORO-2-HYDROXI-3- (3,4-DIOXO-CICLOBUT-1-ENIL-AMINO) -N-METOXI-N-METHYL-BENCEN-SULPHONAMIDE, SOLVATOS, HYDRAPHS OR PHARMACEUTICALLY ACCEPTED SALTS THE SAME, PREPARATION PROCESS, COMPOSITIONS AND APPLICATIONS. | |
| EA201001205A1 (en) | COMPOUNDS CONTAINING CYCLOBUTOXY GROUP | |
| DE602008001725D1 (en) | 1- (1-BENZYLPIPERIDIN-4-YL) BENZIMIDAZOLE-5-CARBOXYLENE DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS | |
| EA201001087A1 (en) | NEW DIHYDROINDOLONIC COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| PL401473A1 (en) | New, highly fluorescent heterocyclic substances and their preparation | |
| PE20140998A1 (en) | HETEROCYCLIC COMPOUNDS AS SYK INHIBITORS | |
| EA201001855A1 (en) | COMPOUNDS CONTAINING CYCLOBUTOXY GROUP | |
| TH123100A (en) | Quinoxalene - and Clinoline - Carboxamike | |
| EA201001095A1 (en) | COMPOUND (R) -N * 6 * -ethyl-6,7-DIHYDRO-5H-INDENO [5,6-D] TIAZOL-2,6-DIAMINE AND ITS APPLICATION AS ANTIPSYCHOTIC MEANS | |
| TH128002B (en) | Antagonist C5aR | |
| NO20075700L (en) | (+) - and (-) - 8-alkyl-3- (trifluoroalkylsulfonyloxy) -8-azabicyclo (3.2.1) oct-2-ene | |
| ATE522530T1 (en) | 2-PIPERAZINE-1-YL-3H-IMIDAZOÄ4,5-BÜ-PYRIDINE DERIVATIVES | |
| TH77786A (en) | ||
| TH97814A (en) | MGLUR5 Adjuster | |
| TH94330B (en) | 2--Lcoxin-3,4,5-trihydroxy-alkylamine derivatives, these preparations, mixtures containing these substances. And use | |
| TH107958A (en) | Piroll compounds | |
| TH104947B (en) | Cyralcis - Imidazoline |